Related Experiment Video
Updated: Jun 17, 2026
Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
Published on: June 7, 2014
Biological modulation of renal ischemia-reperfusion injury
Maarten G J Snoeijs1, L W Ernest van Heurn, Wim A Buurman
1Department of Surgery, Maastricht University Medical Center, Maastricht, The Netherlands. m.snoeijs@mumc.nl
Purpose Of Review:
Biological modulation of renal ischemia-reperfusion injury holds the potential to reduce the incidence of early graft dysfunction and to safely expand the donor pool with kidneys that have suffered prolonged ischemic injury before organ recovery.
Recent Findings:
In the current review, we will discuss clinical studies that compare kidney transplant recipients with and without early graft dysfunction in order to elucidate the pathophysiology of ischemic acute allograft injury. We will specifically review the mechanisms leading to depression of the glomerular filtration rate and activation of the innate immune system in response to tissue injury.
Summary:
We conclude that the pathophysiology of delayed graft function after kidney transplantation is complex and shares broad similarity with rodent models of ischemic acute kidney injury. Given the lack of specific therapies to prevent delayed graft function in transplant recipients, comprehensive efforts should be initiated to translate the promising findings obtained in small animal models into clinical interventions that attenuate ischemic acute kidney injury after transplantation.
Insights
Biological modulation of kidney ischemia-reperfusion injury can improve graft function and expand the donor pool. Understanding injury mechanisms is key to developing new therapies for delayed graft function after transplantation.
Area of Science:
- Nephrology
- Transplantation Immunology
- Regenerative Medicine
Background:
- Renal ischemia-reperfusion injury (IRI) is a major cause of early graft dysfunction after kidney transplantation.
- Biological modulation strategies aim to mitigate IRI, potentially expanding the donor pool for kidneys with prolonged ischemic times.
Purpose of the Study:
- To review clinical studies comparing kidney transplant recipients with and without early graft dysfunction.
- To elucidate the pathophysiology of ischemic acute allograft injury, focusing on glomerular filtration rate depression and innate immune activation.
Main Methods:
- Review of clinical studies on kidney transplant recipients.
- Analysis of mechanisms underlying ischemic acute kidney injury (AKI).
- Comparison of human IRI pathophysiology with rodent models of AKI.
Main Results:
- Early graft dysfunction in kidney transplant recipients involves complex pathophysiological mechanisms.
- Ischemic acute allograft injury is characterized by reduced glomerular filtration rate and innate immune system activation.
- Rodent models of ischemic AKI share similarities with human IRI pathophysiology.
Conclusions:
- The pathophysiology of delayed graft function (DGF) post-transplantation is intricate.
- Translating findings from small animal models of ischemic AKI to clinical interventions is crucial.
- Developing targeted therapies to attenuate ischemic AKI in transplant recipients is a priority.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:29Acute Kidney Injury II: Pathophysiology